Larissa Marques Bemquerer

Larissa Marques Bemquerer

Auto-generated profile, based on publicly available information

Larissa Marques Bemquerer

Universidade Federal de Minas Gerais, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
SOSicília Rezende Oliveira
Sicília Rezende Oliveira
JAJosé Alcides Almeida de Arruda
José Alcides Almeida de Arruda
ASAyda Henriques Schneider
Ayda Henriques Schneider
LBLarissa Marques Bemquerer
Larissa Marques Bemquerer
RSRayssa Maria Soalheiro de Souza
Rayssa Maria Soalheiro de Souza
TSTarcilia Silva
Tarcilia Silva

1 January 2021 in Brazilian Oral Research
Verified
Journal Article
Open access
ASAlessandra Figueiredo Souza
Alessandra Figueiredo Souza
JAJosé Alcides Almeida de Arruda
José Alcides Almeida de Arruda
FCFernanda Pereira Delgado Costa
Fernanda Pereira Delgado Costa
LBLarissa Marques Bemquerer
Larissa Marques Bemquerer
WCWagner Henriques Castro
Wagner Henriques Castro
TSTarcilia Silva
Tarcilia Silva
The coronavirus disease (COVID-19) has been prioritized in relation to other illnesses considered critical, such as cancer, cardiovascular diseases/stroke, diabetes, and autoimmune diseases. The management of patients with these diseases involves dental care to reduce systemic complications caused by odontogenic infections, and/or to treat oral manifestations of systemic comorbidities. In this regard, the dental care of these individuals must be guaranteed during the pandemic. Although a high risk of exposure to and catching of COVID-19 is expected to befall dental professionals, biosafety guidelines reduce the likelihood of infection. Thus, the current scenario poses challenges, and offers decision-making approaches and tools that facilitate the management of individuals with oral manifestations of chronic and/or critical diseases, using hospital-based services. This article presents an overview for hospital service providers who are at the forefront of COVID-19 care, including a secure protocol, and clinical guidelines based on the experience of the Hospital das Clínicas in Belo Horizonte, a public referral service, supported by the Brazilian National Health System.

8 December 2022 in Oral Diseases
Verified
Journal Article
Closed access
ASAna Carolina Velasco Pondé de Sena
Ana Carolina Velasco Pondé de Sena
JAJosé Alcides Almeida de Arruda
José Alcides Almeida de Arruda
LBLarissa Marques Bemquerer
Larissa Marques Bemquerer
EPErika Soares Pantuzzo
Erika Soares Pantuzzo
FKFabiana Maria Kakehasi
Fabiana Maria Kakehasi
TSTarcilia Silva
Tarcilia Silva

1 January 2025 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
ASAlessandra Figueiredo de Souza
Alessandra Figueiredo de Souza
SBSâmila Gonçalves Barra
Sâmila Gonçalves Barra
ARAmanda Leal Rocha
Amanda Leal Rocha
LBLarissa Marques Bemquerer
Larissa Marques Bemquerer
SOSicilia Rezende Oliveira
Sicilia Rezende Oliveira
TSTarcilia Silva
Tarcilia Silva
The use of aromatase inhibitors (AIs) leads to an imbalance in bone remodeling and can cause osteoporosis. This study aimed to identify clinical, periodontal, nutritional, and biochemical determinants of bone mineral density (BMD) changes in patients using AIs. The sample consisted of 40 women using AIs and 32 controls. BMD was assessed by dual X-ray absorptiometry (DXA). Data on nutritional, anthropometric, oral and periodontal status, and oral health-related quality of life (OHRQoL) were collected. Cytokines and adipokines were quantified in saliva and serum. Thirty-nine of the 72 women had low BMD, with a similar distribution in the control and AIs groups. BMD was lower in older women using AIs (p = 0.009) and in smokers (p = 0.034). Anthropometric assessment demonstrated that women with low BMD who used AIs had lower weight (p = 0.028). Although the frequency of periodontitis was similar in all groups, higher IL-6 (p = 0.004), IL-1β (p = 0.002), and IL-33 (p = 0.006) levels were associated with poor periodontal status. Women who used AIs were 1.18 times more likely to report better OHRQoL than controls. While advanced age, smoking, and lower weight are factors associated with low BMD, the use of antiresorptive agents was a protective factor for maintaining BMD in women using AIs.